Your session is about to expire
← Back to Search
Supportive Care + Nutritional Counseling for Pancreatic Cancer
N/A
Waitlist Available
Led By Pamela Hodul, MD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥18 years old
Able to speak and read English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial assesses a new program that provides nutrition and supportive care to pancreatic cancer patients undergoing chemotherapy.
Who is the study for?
Adults over 18 with newly diagnosed or recurrent pancreatic cancer who are starting chemotherapy can join. They must be able to consent, speak English or Spanish, and not have serious psychiatric issues, another GI cancer treatment, poor physical function (ECOG status >2), recent chemo for recurrence, or use tube feeding.Check my eligibility
What is being tested?
The STRONG program is being tested for its effectiveness in providing nutritional guidance and supportive care using tools like Fitbit data collection and surveys (Fact G Survey, GAD-7, PHQ-9) to improve the well-being of patients undergoing chemotherapy for pancreatic cancer.See study design
What are the potential side effects?
There may not be direct side effects from the STRONG program itself as it involves non-invasive support measures. However, participants may experience emotional discomfort when discussing their health condition during counseling sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I can speak and read English or Spanish.
Select...
I have been recently diagnosed with advanced or recurrent pancreatic cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Data Collection - Feasibility
Participant Rating on Ease of Use for the Mobile Application - Usability
Recruitment Rate - Feasibility
Secondary outcome measures
Participant Compliance with Dietary Log - Intervention Adherence
Participant Compliance with Dietician Visits - Intervention Adherence
Participant Compliance with Palliative Care Visits - Intervention Adherence
Trial Design
1Treatment groups
Experimental Treatment
Group I: Nutritional SupportExperimental Treatment5 Interventions
Participants will receive individually tailored, bi-weekly nutrition counseling from a dietician via telehealth and remote monitoring through a smart phone app and wearable sensor to allow participants to log food intake while sharing data with a dietician
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutrition Counseling
2015
Completed Phase 2
~320
Find a Location
Who is running the clinical trial?
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
542 Previous Clinical Trials
135,442 Total Patients Enrolled
Canopy Cancer CollectiveUNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled
Pamela Hodul, MDPrincipal InvestigatorMoffitt Cancer Center
4 Previous Clinical Trials
163 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently being treated for another primary cancer in my digestive system.I have fluid buildup due to cancer in my abdomen.You are receiving nutrition through a tube or intravenously.I am 18 years old or older.I can speak and read English or Spanish.I have been recently diagnosed with advanced or recurrent pancreatic cancer.I need some help with my daily activities.I have received chemotherapy for recurrent pancreatic cancer in the last 6 months.I plan to start chemotherapy as advised by Moffitt.
Research Study Groups:
This trial has the following groups:- Group 1: Nutritional Support
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor currently recruiting participants?
"Per the information on clinicaltrials.gov, this trial is currently in need of volunteers and has been since June 22nd 2022. The post was most recently updated October 27th 2022."
Answered by AI
How many participants have been enrolled in this research endeavor?
"Indeed, the information presented on clinicaltrials.gov confirms that this medical experiment is presently recruiting for participants. This trial was first published on June 22nd 2022 and has been updated as recently as October 27th of the same year; 50 patients are sought from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger